Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Andres Jose Yarur MD

Andres Jose Yarur MD

Assistant Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Gastroenterology
Program: Clinical


Publications (32)

  • Higher Trough Vedolizumab Concentrations During Maintenance Therapy are Associated With Corticosteroid-Free Remission in Inflammatory Bowel Disease. (Ungaro RC, Yarur A, Jossen J, Phan BL, Chefitz E, Sehgal P, Kamal K, Bruss A, Beniwal-Patel P, Fox C, Patel A, Bahur B, Jain A, Stein D, Naik S, Dubinsky MC) J Crohns Colitis 2019 Aug 14;13(8):963-969 PMID: 31087100 SCOPUS ID: 2-s2.0-85065479019 05/16/2019       4 Citations
  • Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists. (Pérez-Jeldres T, Tyler CJ, Boyer JD, Karuppuchamy T, Yarur A, Giles DA, Yeasmin S, Lundborg L, Sandborn WJ, Patel DR, Rivera-Nieves J) Front Pharmacol 2019;10:212 PMID: 30930775 PMCID: PMC6425155 SCOPUS ID: 2-s2.0-85065909627 04/02/2019    
  • Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases. (Yarur AJ, Bruss A, Naik S, Beniwal-Patel P, Fox C, Jain A, Berens B, Patel A, Ungaro R, Bahur B, Dubinsky M, Stein DJ) Dig Dis Sci 2019 06;64(6):1651-1659 PMID: 30835029 SCOPUS ID: 2-s2.0-85062733413 03/06/2019       4 Citations
  • Correction to: Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study. (Micic D, Yarur A, Gonsalves A, Rao VL, Broadaway S, Cohen R, Dalal S, Gaetano JN, Glick LR, Hirsch A, Pekow J, Sakuraba A, Walk ST, Rubin DT) Dig Dis Sci 2018 10;63(10):2815 PMID: 30136047 SCOPUS ID: 2-s2.0-85052293301 08/24/2018    
  • Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease. (Christensen B, Gibson PR, Micic D, Colman RJ, Goeppinger SR, Kassim O, Yarur A, Weber CR, Cohen RD, Rubin DT) Clin Gastroenterol Hepatol 2019 02;17(3):486-493 PMID: 29751166 SCOPUS ID: 2-s2.0-85051739730 05/12/2018       12 Citations
  • Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety. (Christensen B, Colman RJ, Micic D, Gibson PR, Goeppinger SR, Yarur A, Weber CR, Cohen RD, Rubin DT) Inflamm Bowel Dis 2018 03 19;24(4):849-860 PMID: 29562271 PMCID: PMC6196763 SCOPUS ID: 2-s2.0-85044472969 03/22/2018       7 Citations
  • Inflammatory Cytokine Profile in Crohn's Disease Nonresponders to Optimal Antitumor Necrosis Factor Therapy. (Yarur AJ, Jain A, Quintero MA, Czul F, Deshpande AR, Kerman DH, Abreu MT) J Clin Gastroenterol 2019 Mar;53(3):210-215 PMID: 29517712 PMCID: PMC6127004 SCOPUS ID: 2-s2.0-85061247016 03/09/2018    
  • Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy. (Patel P, Yarur A, Dalal S, Sakuraba A, Rubin DT, Hanauer SB, Hanan I, Raffals LH, Cohen RD, Pekow J) Inflamm Bowel Dis 2018 05 18;24(6):1291-1297 PMID: 29506124 SCOPUS ID: 2-s2.0-85047535624 03/06/2018       1 Citation
  • Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study. (Micic D, Yarur A, Gonsalves A, Rao VL, Broadaway S, Cohen R, Dalal S, Gaetano JN, Glick LR, Hirsch A, Pekow J, Sakuraba A, Walk ST, Rubin DT) Dig Dis Sci 2018 04;63(4):1016-1024 PMID: 29417331 SCOPUS ID: 2-s2.0-85041552638 02/09/2018       3 Citations
  • Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease. (Christensen B, Micic D, Gibson PR, Yarur A, Bellaguarda E, Corsello P, Gaetano JN, Kinnucan J, Rao VL, Reddy S, Singh S, Pekow J, Rubin DT) Aliment Pharmacol Ther 2018 Mar;47(6):753-762 PMID: 29377235 PMCID: PMC5821055 SCOPUS ID: 2-s2.0-85041098583 01/30/2018       22 Citations
  • Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases. (Yarur AJ, Gondal B, Hirsch A, Christensen B, Cohen RD, Rubin DT) J Clin Gastroenterol 2018 07;52(6):537-544 PMID: 28723860 SCOPUS ID: 2-s2.0-85025153468 07/21/2017       6 Citations
  • Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease. (Yarur AJ, Kanagala V, Stein DJ, Czul F, Quintero MA, Agrawal D, Patel A, Best K, Fox C, Idstein K, Abreu MT) Aliment Pharmacol Ther 2017 04;45(7):933-940 PMID: 28211593 SCOPUS ID: 2-s2.0-85013449857 02/18/2017       80 Citations
  • Serum Amyloid A as a Surrogate Marker for Mucosal and Histologic Inflammation in Patients with Crohn's Disease. (Yarur AJ, Quintero MA, Jain A, Czul F, Barkin JS, Abreu MT) Inflamm Bowel Dis 2017 01;23(1):158-164 PMID: 27930409 SCOPUS ID: 2-s2.0-85002057652 12/09/2016       6 Citations
  • Higher Adalimumab Levels Are Associated with Histologic and Endoscopic Remission in Patients with Crohn's Disease and Ulcerative Colitis. (Yarur AJ, Jain A, Hauenstein SI, Quintero MA, Barkin JS, Deshpande AR, Sussman DA, Singh S, Abreu MT) Inflamm Bowel Dis 2016 Feb;22(2):409-15 PMID: 26752470 SCOPUS ID: 2-s2.0-84955604767 01/12/2016       64 Citations
  • Penetrating Disease, Narcotic Use, and Loop Ostomy Are Associated with Ostomy and IBD-related Complications After Ostomy Surgery in Crohn's Disease Patients. (Hirsch A, Yarur AJ, Dezheng H, Rodriquez D, Krugliak Cleveland N, Ali T, Hurst RD, Umanskiy K, Hyman N, Colwell J, Rubin DT) J Gastrointest Surg 2015 Oct;19(10):1852-61 PMID: 26264361 SCOPUS ID: 2-s2.0-84942504433 08/13/2015       8 Citations
  • [Differences by age in clinical features of inflammatory bowel disease]. (Simian D, Estay C, Kronberg U, Yarur A, Castro M, Lubascher J, Acuña R, Quera R) Rev Med Chil 2015 Jun;143(6):689-96 PMID: 26230551 SCOPUS ID: 2-s2.0-84938545791 08/01/2015       1 Citation
  • Endoscopic and histological features of mycophenolate mofetil colitis in patients after solid organ transplantation. (Calmet FH, Yarur AJ, Pukazhendhi G, Ahmad J, Bhamidimarri KR) Ann Gastroenterol 2015 Jul-Sep;28(3):366-373 PMID: 26126799 PMCID: PMC4480174 07/02/2015    
  • Cross-sectional analysis of patient phone calls to an inflammatory bowel disease clinic. (Corral JE, Yarur AJ, Diaz L, Simmons OL, Sussman DA) Ann Gastroenterol 2015 Jul-Sep;28(3):357-365 PMID: 26126710 PMCID: PMC4480173 07/02/2015    
  • Therapeutic Drug Monitoring of Anti-tumor Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases. (Yarur AJ, Rubin DT) Inflamm Bowel Dis 2015 Jul;21(7):1709-18 PMID: 25901974 SCOPUS ID: 2-s2.0-84932174376 04/23/2015       30 Citations
  • The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study. (Yarur AJ, Jain A, Sussman DA, Barkin JS, Quintero MA, Princen F, Kirkland R, Deshpande AR, Singh S, Abreu MT) Gut 2016 Feb;65(2):249-55 PMID: 25670812 SCOPUS ID: 2-s2.0-84958840838 02/12/2015       100 Citations
  • Concentrations of 6-thioguanine nucleotide correlate with trough levels of infliximab in patients with inflammatory bowel disease on combination therapy. (Yarur AJ, Kubiliun MJ, Czul F, Sussman DA, Quintero MA, Jain A, Drake KA, Hauenstein SI, Lockton S, Deshpande AR, Barkin JS, Singh S, Abreu MT) Clin Gastroenterol Hepatol 2015 Jun;13(6):1118-24.e3 PMID: 25562796 SCOPUS ID: 2-s2.0-84928628450 01/07/2015       91 Citations
  • Letter: is there a bi-directional relationship between depression and IBD? Authors' reply. (Panara AJ, Yarur AJ, Sussman DA) Aliment Pharmacol Ther 2014 Jul;40(2):214 PMID: 24946065 SCOPUS ID: 2-s2.0-84902792555 06/20/2014    
  • Hepatobiliary manifestations of inflammatory bowel disease. (Yarur AJ, Czul F, Levy C) Inflamm Bowel Dis 2014 Sep;20(9):1655-67 PMID: 24874461 SCOPUS ID: 2-s2.0-84925865005 05/31/2014       12 Citations
  • Letter: psychological remission - a future endpoint in inflammatory bowel disease? Authors' reply. (Panara AJ, Yarur AJ, Sussman DA) Aliment Pharmacol Ther 2014 Jun;39(12):1436-7 PMID: 24849159 SCOPUS ID: 2-s2.0-84901361111 05/23/2014       1 Citation
  • Back to the beginning: restarting infliximab in inflammatory bowel disease patients with prior loss of response. (Yarur AJ, Abreu MT) Clin Gastroenterol Hepatol 2014 Sep;12(9):1482-4 PMID: 24735794 SCOPUS ID: 2-s2.0-84906791375 04/17/2014    
  • Therapeutic drug monitoring in patients with inflammatory bowel disease. (Yarur AJ, Abreu MT, Deshpande AR, Kerman DH, Sussman DA) World J Gastroenterol 2014 Apr 07;20(13):3475-84 PMID: 24707130 PMCID: PMC3974514 SCOPUS ID: 2-s2.0-84897483249 04/08/2014       40 Citations
  • The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: a cohort study. (Panara AJ, Yarur AJ, Rieders B, Proksell S, Deshpande AR, Abreu MT, Sussman DA) Aliment Pharmacol Ther 2014 Apr;39(8):802-10 PMID: 24588323 SCOPUS ID: 2-s2.0-84896397559 03/05/2014       47 Citations
  • Predictive factors for clinically actionable computed tomography findings in inflammatory bowel disease patients seen in the emergency department with acute gastrointestinal symptoms. (Yarur AJ, Mandalia AB, Dauer RM, Czul F, Deshpande AR, Kerman DH, Abreu MT, Sussman DA) J Crohns Colitis 2014 Jun;8(6):504-12 PMID: 24275204 SCOPUS ID: 2-s2.0-84899906180 11/28/2013       10 Citations
  • The impact of Hispanic ethnicity and race on post-surgical complications in patients with inflammatory bowel disease. (Yarur AJ, Abreu MT, Salem MS, Deshpande AR, Sussman DA) Dig Dis Sci 2014 Jan;59(1):126-34 PMID: 23483313 03/14/2013    
  • Prevalence of thyroid cancer in multinodular goiter versus single nodule: a systematic review and meta-analysis. (Brito JP, Yarur AJ, Prokop LJ, McIver B, Murad MH, Montori VM) Thyroid 2013 Apr;23(4):449-55 PMID: 23067375 SCOPUS ID: 2-s2.0-84875724306 10/17/2012       56 Citations
  • Predictors of aggressive inflammatory bowel disease. (Yarur AJ, Strobel SG, Deshpande AR, Abreu MT) Gastroenterol Hepatol (N Y) 2011 Oct;7(10):652-9 PMID: 22298958 PMCID: PMC3265007 02/03/2012    
  • Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. (Yarur AJ, Deshpande AR, Pechman DM, Tamariz L, Abreu MT, Sussman DA) Am J Gastroenterol 2011 Apr;106(4):741-7 PMID: 21386828 SCOPUS ID: 2-s2.0-79953792907 03/10/2011       121 Citations
  • Last update: 10/14/2019
    jenkins-FCD Prod-410 e9586552fe7f53c71f7923aa6e27aeabbd3c2473